Differentiated Thyroid Cancer (DTC) Recruiting Phase 2 Trials for Lenvatinib (DB09078)

Also known as: Differentiated Thyroid Cancer

IndicationStatusPhase
DBCOND0062237 (Differentiated Thyroid Cancer (DTC))Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs